These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Electrochemotherapy as a single or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: a 31-case retrospective study. Tozon N, Kramaric P, Kos Kadunc V, Sersa G, Cemazar M. Vet Rec; 2016 Dec 17; 179(24):627. PubMed ID: 27758950 [Abstract] [Full Text] [Related]
3. [Treatment of equine sarcoids with cisplatin in arachid oil: a useful alternative?]. Spoormakers TJ, Klein WR, van Weeren PR. Tijdschr Diergeneeskd; 2002 Jun 01; 127(11):350-4. PubMed ID: 12073779 [Abstract] [Full Text] [Related]
4. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours. Kodre V, Cemazar M, Pecar J, Sersa G, Cor A, Tozon N. In Vivo; 2009 Jun 01; 23(1):55-62. PubMed ID: 19368125 [Abstract] [Full Text] [Related]
5. Electrochemotherapy of horses. A preliminary clinical report. Rols MP, Tamzali Y, Teissié J. Bioelectrochemistry; 2002 Jan 01; 55(1-2):101-5. PubMed ID: 11786351 [Abstract] [Full Text] [Related]
6. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004). Théon AP, Wilson WD, Magdesian KG, Pusterla N, Snyder JR, Galuppo LD. J Am Vet Med Assoc; 2007 May 15; 230(10):1506-13. PubMed ID: 17504043 [Abstract] [Full Text] [Related]
8. Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004). Hewes CA, Sullins KE. J Am Vet Med Assoc; 2006 Nov 15; 229(10):1617-22. PubMed ID: 17107319 [Abstract] [Full Text] [Related]
9. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses. Théon AP, Pascoe JR, Galuppo LD, Fisher PE, Griffey SM, Madigan JE. J Am Vet Med Assoc; 1999 Dec 01; 215(11):1655-60. PubMed ID: 14567430 [Abstract] [Full Text] [Related]
11. The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision. Lowe R, Gavazza A, Impellizeri JA, Soden DM, Lubas G. Vet Comp Oncol; 2017 Sep 01; 15(3):775-784. PubMed ID: 27001443 [Abstract] [Full Text] [Related]
15. Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness. Spugnini EP, Melillo A, Quagliuolo L, Boccellino M, Vincenzi B, Pasquali P, Baldi A. J Cell Physiol; 2014 Sep 01; 229(9):1177-81. PubMed ID: 24403005 [Abstract] [Full Text] [Related]
17. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Tozon N, Sersa G, Cemazar M. Anticancer Res; 2001 Sep 01; 21(4A):2483-8. PubMed ID: 11724311 [Abstract] [Full Text] [Related]
18. Utility of electrochemotherapy in melanoma treatment. Testori A, Rossi CR, Tosti G. Curr Opin Oncol; 2012 Mar 01; 24(2):155-61. PubMed ID: 22249204 [Abstract] [Full Text] [Related]
19. Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Spugnini EP, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N, Baldi A. Vet J; 2009 Jan 01; 179(1):117-20. PubMed ID: 17904882 [Abstract] [Full Text] [Related]
20. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Cemazar M, Miklavcic D, Scancar J, Dolzan V, Golouh R, Sersa G. Br J Cancer; 1999 Mar 01; 79(9-10):1386-91. PubMed ID: 10188880 [Abstract] [Full Text] [Related] Page: [Next] [New Search]